Indrayani Biotech Ltd
₹8.08
(-1.10%)
Wed, 04 Mar 2026, 02:39 pm
Consumer Services
Restaurants
24.5KIndrayani Biotech Debt to Equity Ratio
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.77 | 0 | 23.51 | 16.21 | 21.48 | 0 |
| Price to book ratio | 0 | 0 | 4.18 | 4.20 | 4.31 | 4.40 | 4.53 | 0.62 | 0.57 | 0 | 0 | 0.10 | 1.10 | 4.32 | 3.51 | 3.33 | 0.90 |
| Price to sales ratio | 3.76 | 8.60 | 0.38 | 0.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 1.05 | 1.70 | 1.19 | 1.35 | 0.50 |
| Price to cash flow ratio | 0 | 0 | 17.02 | 10.89 | 223.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0.63 | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 8.6M | 17.14M | 167.56M | 154.13M | 148.36M | 149.02M | 149.93M | 23.08M | 21.85M | 26.88M | 31.87M | 153.82M | 369.51M | 1.22B | 2.55B | 3.45B | 2.29B |
| Enterprise value to EBITDA ratio | 0 | 0 | 18.66 | 20.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.53 | 0 | 18 | 14.75 | 14.58 | 35.51 |
| Debt to equity ratio | 0 | 0 | 0.62 | 0.53 | 0.04 | 0.04 | 0.08 | 0.13 | 0.16 | 0 | 0 | 0.45 | 0.79 | 0.78 | 1.30 | 1.67 | 1.89 |
| Return on equity % | 0 | 0 | -3.12 | -1.84 | -0.18 | -2.06 | -3.06 | -4.05 | -7.84 | -10.24 | 0 | 5.35 | -117.94 | 20.23 | 30.11 | 17.04 | -8.74 |
Indrayani Biotech Ltd Debt to Equity Ratio
The Indrayani Biotech Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Indrayani Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Indrayani Biotech Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Indrayani Biotech Ltd (NSE: , BSE: 526445) is currently trading at ₹8.08, with a market capitalization of ₹367.93M. As a leading company in the Consumer services sector and Restaurants industry, monitoring the Indrayani Biotech Ltd Debt to Equity Ratio is essential for fundamental analysis.
Indrayani Biotech Ltd Debt to Equity Ratio Current Value
The current Indrayani Biotech Ltd Debt to Equity Ratio stands at 1.89.
The latest Indrayani Biotech Ltd Debt to Equity Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Indrayani Biotech Ltd Debt to Equity Ratio Historical Trend
The Indrayani Biotech Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 1.89
- 2023: 1.67
- 2022: 1.30
- 2021: 0.78
- 2020: 0.79
The recent rise in Indrayani Biotech Ltd Debt to Equity Ratio suggests strengthening valuation trends and improving market sentiment.
What Indrayani Biotech Ltd Debt to Equity Ratio Indicates for Investors
The Indrayani Biotech Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Indrayani Biotech Ltd Debt to Equity Ratio Analysis Summary
The Indrayani Biotech Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Indrayani Biotech Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Indrayani Biotech Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800